CN216209059U - Total nitrogen tester for famotidine - Google Patents
Total nitrogen tester for famotidine Download PDFInfo
- Publication number
- CN216209059U CN216209059U CN202122457867.8U CN202122457867U CN216209059U CN 216209059 U CN216209059 U CN 216209059U CN 202122457867 U CN202122457867 U CN 202122457867U CN 216209059 U CN216209059 U CN 216209059U
- Authority
- CN
- China
- Prior art keywords
- fixedly connected
- gear
- supporting
- supporting frame
- total nitrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 title claims abstract description 40
- 229960001596 famotidine Drugs 0.000 title claims abstract description 23
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 title claims abstract description 23
- 229910052757 nitrogen Inorganic materials 0.000 title claims abstract description 20
- 238000009434 installation Methods 0.000 claims description 5
- 244000309464 bull Species 0.000 claims description 4
- 210000004211 gastric acid Anatomy 0.000 description 4
- 230000006835 compression Effects 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 229940122957 Histamine H2 receptor antagonist Drugs 0.000 description 2
- 101150056637 Hrh2 gene Proteins 0.000 description 2
- 230000003139 buffering effect Effects 0.000 description 2
- 229960001380 cimetidine Drugs 0.000 description 2
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 2
- 239000003485 histamine H2 receptor antagonist Substances 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010079943 Pentagastrin Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 206010046274 Upper gastrointestinal haemorrhage Diseases 0.000 description 1
- 201000008629 Zollinger-Ellison syndrome Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002280 anti-androgenic effect Effects 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- -1 apparatus body 1 Chemical compound 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036267 drug metabolism Effects 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 201000000052 gastrinoma Diseases 0.000 description 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 1
- 150000008326 guanidinothiazoles Chemical class 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- ANRIQLNBZQLTFV-DZUOILHNSA-N pentagastrin Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1[C]2C=CC=CC2=NC=1)NC(=O)CCNC(=O)OC(C)(C)C)CCSC)C(N)=O)C1=CC=CC=C1 ANRIQLNBZQLTFV-DZUOILHNSA-N 0.000 description 1
- 229960000444 pentagastrin Drugs 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 208000000689 peptic esophagitis Diseases 0.000 description 1
- 229960000620 ranitidine Drugs 0.000 description 1
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Investigation Of Foundation Soil And Reinforcement Of Foundation Soil By Compacting Or Drainage (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202122457867.8U CN216209059U (en) | 2021-10-13 | 2021-10-13 | Total nitrogen tester for famotidine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202122457867.8U CN216209059U (en) | 2021-10-13 | 2021-10-13 | Total nitrogen tester for famotidine |
Publications (1)
Publication Number | Publication Date |
---|---|
CN216209059U true CN216209059U (en) | 2022-04-05 |
Family
ID=80864582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202122457867.8U Active CN216209059U (en) | 2021-10-13 | 2021-10-13 | Total nitrogen tester for famotidine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN216209059U (en) |
-
2021
- 2021-10-13 CN CN202122457867.8U patent/CN216209059U/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN216209059U (en) | Total nitrogen tester for famotidine | |
CN210979229U (en) | Information communication signal detection device | |
CN217951762U (en) | Be used for territory space planning data acquisition mapping device | |
CN217211952U (en) | Detection apparatus for compound bearing capacity of tunnel anchor country rock | |
CN216298012U (en) | Perforating device for watch processing | |
CN217055011U (en) | Shale gas exploration sampling pretreatment device | |
CN215812539U (en) | Engineering machine tool electronic monitor | |
CN115013665A (en) | Foundation pile self-balancing method static test displacement observation platform device | |
CN210513150U (en) | Building construction measuring device | |
CN213936487U (en) | High-rigidity resonance rod | |
CN110578467B (en) | Coal exploitation sampling device | |
CN221075774U (en) | Lifting equipment base structure | |
CN221899255U (en) | Positioning detection device for electronic product | |
CN221855533U (en) | Soil and stone side is filled and is constructed and pile foundation engineering supporting construction | |
CN114674205B (en) | Green building decoration wall roughness detection device with lifting function | |
CN221527807U (en) | Movable electronic scale | |
CN213420526U (en) | Electronic menu device with video function | |
CN220888590U (en) | Highway soft foundation monitoring devices | |
CN221772297U (en) | Humiture environment detection case with adjustable | |
CN221066223U (en) | Electromechanical device installation and debugging platform | |
CN214667854U (en) | Oil sampling device for oil and gas field development | |
CN215640090U (en) | Testing arrangement of dish knot formula steel pipe support load | |
CN217634870U (en) | Auxiliary support for engineering measuring instrument | |
CN221121730U (en) | Portable mapping device | |
CN221229106U (en) | Planning sand table for marketing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Suzhou Zhengji Pharmaceutical Co.,Ltd. Assignor: JIANGSU ZENJI PHARMACEUTICALS LTD. Contract record no.: X2024980015147 Denomination of utility model: A total nitrogen analyzer for famotidine Granted publication date: 20220405 License type: Common License Record date: 20240913 Assignee: Rizhao Zhengji Pharmaceutical Co.,Ltd. Assignor: JIANGSU ZENJI PHARMACEUTICALS LTD. Contract record no.: X2024980015140 Denomination of utility model: A total nitrogen analyzer for famotidine Granted publication date: 20220405 License type: Common License Record date: 20240913 |
|
EE01 | Entry into force of recordation of patent licensing contract |